RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYRISE OF AI AND ANALYTICS IN OPHTHALMOLOGY MARKET OVERVIEW 3...
Transcript of RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYRISE OF AI AND ANALYTICS IN OPHTHALMOLOGY MARKET OVERVIEW 3...
ois.net #OISAAO
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGY
INTERWEST PARTNERSGILBERT H. KLIMAN, MD
MODERATED BY:MODERATED BY:
ois.net #OISAAO
VERILY LIFE SCIENCES
DIMITRIAZAR, MD
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYMARKET OVERVIEW
3
ois.net #OISAAO
GENENTECH
JILLHOPKINS, MD
VERILY LIFE SCIENCES
DIMITRIAZAR, MD
CARL ZEISS MEDITEC
ANGELORAGO
PHILIPS
DALEWIGGINS
INTERWEST PARTNERS
GILBERT H.KLIMAN, MD
MODERATED BY:
SANTEN
ELLIECHABI, MD
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYSTRATEGIC PANEL
4
ois.net #OISAAO
5
Dale WigginsVP & GM HealthSuite digital platform
AI in Healthcare
Applying AI to enable integrated personalized care anytime, anywhere and to support optimized care operations
Context Context
Personalized care
Adaptive IntelligenceAdaptive: dynamically change in response to you
Embedded: connected devices integrated into the environment
Context-aware: devices recognize you and your context
Natural: converse in a natural way
Precise: multi-modality perspective to get precise measurements and insights
Personalized: configured to your needs
Predictive: anticipate your condition & needs
Pro-active: preventative, early intervention Digital Twin
Protecting the World’s Vision
Copyright© 2018 Santen Inc. All rights reserved.
OIS@AAO 2018Ellie Chabi, MD | Therapeutic Area Head, Glaucoma & Neuroprotection
October 25, 2018
A STRONG FOUNDATION IN OPHTHALMOLOGY
Countries where specialty ophthalmic products are sold
Established in Osaka, Japan, the first ophthalmology company of its kind
First ophthalmic product launched
1890
60+
$2.25
1899
Employees worldwide 4,000
Billion in revenue in FY2017
SANTEN COMMITMENTPreserving vision with innovative ophthalmic products
Exclusive to ophthalmology with a
long-term view
Accelerate innovation through strategic
partnerships
Develop therapeutic solutions focused on
unmet needs
1. THERAPEUTIC SOLUTIONS, INCLUDING: • Glaucoma & Neuroprotection• Retinal Diseases• Dry Eye and External Diseases
Partnering Opportunities
2. MACHINE LEARNING / AI3. BIOMARKERS AND DIAGNOSTIC TOOLS4. DRUG DELIVERY
ois.net #OISAAO
13
ois.net #OISAAO
GENENTECH
JILLHOPKINS, MD
VERILY LIFE SCIENCES
DIMITRIAZAR, MD
CARL ZEISS MEDITEC
ANGELORAGO
PHILIPS
DALEWIGGINS
INTERWEST PARTNERS
GILBERT H.KLIMAN, MD
MODERATED BY:
SANTEN
ELLIECHABI, MD
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYSTRATEGIC PANEL
14
ois.net #OISAAO
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGYPRESENTING COMPANIES
15
ois.net #OISAAO
Potential Questions for Companies• What are the data inputs and what algorithms drive your technology?• Is the process fixed or is there “machine learning” involved?• To what degree are humans required for interpretation/operation?• What FDA approval is required and who pays for the technology?• What interventions can be driven directly or indirectly by the technology?
16
ois.net #OISAAO
RISE OF AI AND ANALYTICS IN OPHTHALMOLOGY
Thank you!
17